To Toci or Not to Toci for Coronavirus Disease 2019 (COVID-19): Is That Still the Question?

Cheng, Guang-Shing; Hill, Joshua A

Cheng, Guang-Shing; Hill, Joshua A.

Cheng GS; Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, Washington, USA.
Hill JA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Clin Infect Dis ; 73(2): e455-e457, 2021 07 15.

Article in English | MEDLINE | ID: covidwho-1315665

Subject(s)

COVID-19; Antibodies, Monoclonal, Humanized; Humans; SARS-CoV-2

Keywords

COVID-19; SARS-CoV-2; coronavirus; immunomodulatory; tocilizumab

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google